Patients With Kidney Cancer in Stages III and IV May Benefit from the Cancer Vaccination
Surgery to remove the tumor is the standard of care for individuals with stage III or IV clear cell renal cell carcinoma.
Surgery to remove the tumor is the standard of care for individuals with stage III or IV clear cell renal cell carcinoma.
In preclinical models tested in mice, a possible novel targeted therapy for children brain cancer has been found to be successful in infiltrating and destroying tumor cells
Data from this 28-country multi-institutional effort helped the Food and Drug Administration (FDA) approve this combination more quickly in December 2024, giving patients with BRAF V600E-mutant mCRC a new and effective first-line treatment choice.
The huntingtin gene’s three DNA blocks (C, A, and G) repeatedly expanding are the source of the illness.
The recovery process for patients with acute spinal cord injuries can be enhanced by antibodies. This has been studied with encouraging results by researchers at 13 clinics in Germany, Switzerland, the Czech Republic, and Spain. For the first time, patient groups exhibiting a treatment impact that was clinically relevant could be identified. December 2024 will see the start of a follow-up study.
A twice-yearly injection of Lenacapavir, however, offers a 96% lower risk of infection overall.
A class of tumors known as soft tissue sarcoma of the extremities develops in the muscles, tendons, fat, blood vessels, or nerves of the arms and leg
Teri Boudreaux is thankful for the time she gets to spend with her family, whether it’s hiking, playing with her grandkids, travelling with her spouse, [Read More…]
The outcomes of an international Phase III clinical trial conducted by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group [Read More…]
A novel vaccine candidate that offers protection against Lassa fever has been developed by researchers from Thomas Jefferson University and the University of Maryland Baltimore, [Read More…]